Robert Glenning

Business address
C/O Eagle Pharmaceuticals, Inc., 50 Tice Blvd Suite 315, Woodcliff Lake, NJ, 07677
Top holdings (ownership)
EGRX
Get insider transactions for this reporting owner
Robert Glenning has filed 9 SEC EDGAR filings since 06 Jul 2016

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 SUBMISSION 09 Mar 2023 07 Mar 2023 001-36306
4 Open Document Open Filing FORM 4 SUBMISSION 02 Mar 2022 28 Feb 2022 001-36306
4 Open Document Open Filing FORM 4 SUBMISSION 04 Feb 2021 02 Feb 2021 001-36306
4 Open Document Open Filing FORM 4 SUBMISSION 07 Jan 2020 05 Jan 2020 001-36306
4 Open Document Open Filing FORM 4 SUBMISSION 25 Jan 2019 23 Jan 2019 001-36306
4 Open Document Open Filing FORM 4 SUBMISSION 09 Jan 2018 07 Jan 2018 001-36306
4 Open Document Open Filing FORM 4 SUBMISSION 06 Jan 2017 04 Jan 2017 001-36306
4 Open Document Open Filing FORM 4 SUBMISSION 06 Jul 2016 05 Jul 2016 001-36306
3 Open Document Open Filing FORM 3 SUBMISSION 06 Jul 2016 05 Jul 2016 001-36306